Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(Non small cell lung cancer). Showing records 1 – 30 of 88028 total matches.

[1] [2] [3] [4] [5] … [2935]

Search Limiters

Last 2 Years | English Only

Degrees

Levels

Languages

Country

▼ Search Limiters


Universiteit Utrecht

1. Waal, L.M. de. Treatment of subtypes in non-small cell lung cancer.

Degree: 2012, Universiteit Utrecht

Lung cancer accounts for the highest number of cancer related deaths among all cancer patients. It has been well established that exposure to tobacco significantly… (more)

Subjects/Keywords: lung cancer; treatment; targeted therapy; non-small cell lung cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Waal, L. M. d. (2012). Treatment of subtypes in non-small cell lung cancer. (Masters Thesis). Universiteit Utrecht. Retrieved from http://dspace.library.uu.nl:8080/handle/1874/241663

Chicago Manual of Style (16th Edition):

Waal, L M de. “Treatment of subtypes in non-small cell lung cancer.” 2012. Masters Thesis, Universiteit Utrecht. Accessed June 01, 2020. http://dspace.library.uu.nl:8080/handle/1874/241663.

MLA Handbook (7th Edition):

Waal, L M de. “Treatment of subtypes in non-small cell lung cancer.” 2012. Web. 01 Jun 2020.

Vancouver:

Waal LMd. Treatment of subtypes in non-small cell lung cancer. [Internet] [Masters thesis]. Universiteit Utrecht; 2012. [cited 2020 Jun 01]. Available from: http://dspace.library.uu.nl:8080/handle/1874/241663.

Council of Science Editors:

Waal LMd. Treatment of subtypes in non-small cell lung cancer. [Masters Thesis]. Universiteit Utrecht; 2012. Available from: http://dspace.library.uu.nl:8080/handle/1874/241663


University of Toronto

2. Ting Hai, Josephine Wun. Functional Analysis of Novel Prognostic Markers of Non-small Cell Lung Cancer.

Degree: PhD, 2014, University of Toronto

Non-small cell lung cancer (NSCLC) is the leading cause of cancer deaths worldwide. Global expression profiling of patient tumours has identified hundreds of genes controlling… (more)

Subjects/Keywords: lung cancer; Non-small cell lung cancer; 0992

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Ting Hai, J. W. (2014). Functional Analysis of Novel Prognostic Markers of Non-small Cell Lung Cancer. (Doctoral Dissertation). University of Toronto. Retrieved from http://hdl.handle.net/1807/79814

Chicago Manual of Style (16th Edition):

Ting Hai, Josephine Wun. “Functional Analysis of Novel Prognostic Markers of Non-small Cell Lung Cancer.” 2014. Doctoral Dissertation, University of Toronto. Accessed June 01, 2020. http://hdl.handle.net/1807/79814.

MLA Handbook (7th Edition):

Ting Hai, Josephine Wun. “Functional Analysis of Novel Prognostic Markers of Non-small Cell Lung Cancer.” 2014. Web. 01 Jun 2020.

Vancouver:

Ting Hai JW. Functional Analysis of Novel Prognostic Markers of Non-small Cell Lung Cancer. [Internet] [Doctoral dissertation]. University of Toronto; 2014. [cited 2020 Jun 01]. Available from: http://hdl.handle.net/1807/79814.

Council of Science Editors:

Ting Hai JW. Functional Analysis of Novel Prognostic Markers of Non-small Cell Lung Cancer. [Doctoral Dissertation]. University of Toronto; 2014. Available from: http://hdl.handle.net/1807/79814


University of Toronto

3. Tan, Samuel ZhiXing. Non-genetic Resistant Mechanism to EGFR Tyrosine Kinase Inhibitory Therapy.

Degree: 2015, University of Toronto

Despite initial high response rate to tyrosine kinase inhibitor (TKI) treatment, non-small cell lung cancer (NSCLC) patients whose tumors harbour activating mutation in their epidermal… (more)

Subjects/Keywords: drug resistance; lung cancer; non-small cell lung cancer; tyrosine kinase inhibitor; 0379

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Tan, S. Z. (2015). Non-genetic Resistant Mechanism to EGFR Tyrosine Kinase Inhibitory Therapy. (Masters Thesis). University of Toronto. Retrieved from http://hdl.handle.net/1807/75270

Chicago Manual of Style (16th Edition):

Tan, Samuel ZhiXing. “Non-genetic Resistant Mechanism to EGFR Tyrosine Kinase Inhibitory Therapy.” 2015. Masters Thesis, University of Toronto. Accessed June 01, 2020. http://hdl.handle.net/1807/75270.

MLA Handbook (7th Edition):

Tan, Samuel ZhiXing. “Non-genetic Resistant Mechanism to EGFR Tyrosine Kinase Inhibitory Therapy.” 2015. Web. 01 Jun 2020.

Vancouver:

Tan SZ. Non-genetic Resistant Mechanism to EGFR Tyrosine Kinase Inhibitory Therapy. [Internet] [Masters thesis]. University of Toronto; 2015. [cited 2020 Jun 01]. Available from: http://hdl.handle.net/1807/75270.

Council of Science Editors:

Tan SZ. Non-genetic Resistant Mechanism to EGFR Tyrosine Kinase Inhibitory Therapy. [Masters Thesis]. University of Toronto; 2015. Available from: http://hdl.handle.net/1807/75270

4. Svensson, Susanne. In vitro and in vivo inhibition of Chk1 sensitize lung cancer stem cells to chemotherapy.

Degree: 2011, Università degli Studi di Catania

 Development of resistance to radiation and chemotherapy turns the treatment of solid cancers into a therapeutic challenge. One of the most exciting breakthroughs being explored… (more)

Subjects/Keywords: Non-small cell lung cancer; Lung cancer stem cells; DNA damage; Chk1 inhibitors

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Svensson, S. (2011). In vitro and in vivo inhibition of Chk1 sensitize lung cancer stem cells to chemotherapy. (Thesis). Università degli Studi di Catania. Retrieved from http://hdl.handle.net/10761/98

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Svensson, Susanne. “In vitro and in vivo inhibition of Chk1 sensitize lung cancer stem cells to chemotherapy.” 2011. Thesis, Università degli Studi di Catania. Accessed June 01, 2020. http://hdl.handle.net/10761/98.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Svensson, Susanne. “In vitro and in vivo inhibition of Chk1 sensitize lung cancer stem cells to chemotherapy.” 2011. Web. 01 Jun 2020.

Vancouver:

Svensson S. In vitro and in vivo inhibition of Chk1 sensitize lung cancer stem cells to chemotherapy. [Internet] [Thesis]. Università degli Studi di Catania; 2011. [cited 2020 Jun 01]. Available from: http://hdl.handle.net/10761/98.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Svensson S. In vitro and in vivo inhibition of Chk1 sensitize lung cancer stem cells to chemotherapy. [Thesis]. Università degli Studi di Catania; 2011. Available from: http://hdl.handle.net/10761/98

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

5. Inoue, Kazuya; Hontsu, Shigeto; Miura, Sachiko; Asakawa, Isao; Tamamoto, Tetsuro; Yoshimine, Tadashi; Kimura, Hiroshi. Feasibility and efficacy of definitive radiotherapy with 66 GY and concurrent carboplatin-paclitaxel chemotherapy for stage Ⅲ non-small cell lung cancer. : Ⅲ期非小細胞肺癌に対するカルボプラチン・パクリタキセル同時併用66Gy放射線治療の安全性と有効性について.

Degree: 博士(医学), 2017, Nara Medical University / 奈良県立医科大学

Purpose/Objectives: This study was conducted to assess the feasibility and efficacy of definitive radiotherapy (RT) with a total dose of 66Gy and concurrent carboplatin-paclitaxel chemotherapy… (more)

Subjects/Keywords: Non-small cell lung cancer; Concurrent chemoradiotherapy; 66Gy; Carboplatin-paclitaxel chemotherapy

Page 1

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Inoue, Kazuya; Hontsu, Shigeto; Miura, Sachiko; Asakawa, Isao; Tamamoto, Tetsuro; Yoshimine, Tadashi; Kimura, H. (2017). Feasibility and efficacy of definitive radiotherapy with 66 GY and concurrent carboplatin-paclitaxel chemotherapy for stage Ⅲ non-small cell lung cancer. : Ⅲ期非小細胞肺癌に対するカルボプラチン・パクリタキセル同時併用66Gy放射線治療の安全性と有効性について. (Thesis). Nara Medical University / 奈良県立医科大学. Retrieved from http://hdl.handle.net/10564/3314

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Inoue, Kazuya; Hontsu, Shigeto; Miura, Sachiko; Asakawa, Isao; Tamamoto, Tetsuro; Yoshimine, Tadashi; Kimura, Hiroshi. “Feasibility and efficacy of definitive radiotherapy with 66 GY and concurrent carboplatin-paclitaxel chemotherapy for stage Ⅲ non-small cell lung cancer. : Ⅲ期非小細胞肺癌に対するカルボプラチン・パクリタキセル同時併用66Gy放射線治療の安全性と有効性について.” 2017. Thesis, Nara Medical University / 奈良県立医科大学. Accessed June 01, 2020. http://hdl.handle.net/10564/3314.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Inoue, Kazuya; Hontsu, Shigeto; Miura, Sachiko; Asakawa, Isao; Tamamoto, Tetsuro; Yoshimine, Tadashi; Kimura, Hiroshi. “Feasibility and efficacy of definitive radiotherapy with 66 GY and concurrent carboplatin-paclitaxel chemotherapy for stage Ⅲ non-small cell lung cancer. : Ⅲ期非小細胞肺癌に対するカルボプラチン・パクリタキセル同時併用66Gy放射線治療の安全性と有効性について.” 2017. Web. 01 Jun 2020.

Vancouver:

Inoue, Kazuya; Hontsu, Shigeto; Miura, Sachiko; Asakawa, Isao; Tamamoto, Tetsuro; Yoshimine, Tadashi; Kimura H. Feasibility and efficacy of definitive radiotherapy with 66 GY and concurrent carboplatin-paclitaxel chemotherapy for stage Ⅲ non-small cell lung cancer. : Ⅲ期非小細胞肺癌に対するカルボプラチン・パクリタキセル同時併用66Gy放射線治療の安全性と有効性について. [Internet] [Thesis]. Nara Medical University / 奈良県立医科大学; 2017. [cited 2020 Jun 01]. Available from: http://hdl.handle.net/10564/3314.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Inoue, Kazuya; Hontsu, Shigeto; Miura, Sachiko; Asakawa, Isao; Tamamoto, Tetsuro; Yoshimine, Tadashi; Kimura H. Feasibility and efficacy of definitive radiotherapy with 66 GY and concurrent carboplatin-paclitaxel chemotherapy for stage Ⅲ non-small cell lung cancer. : Ⅲ期非小細胞肺癌に対するカルボプラチン・パクリタキセル同時併用66Gy放射線治療の安全性と有効性について. [Thesis]. Nara Medical University / 奈良県立医科大学; 2017. Available from: http://hdl.handle.net/10564/3314

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

6. Lazarioti, Fotini. Ανάλυση και συσχέτιση των απεικονιστικών ευρημάτων με την ανταπόκριση στη (α) Λιποπλατίνη και Γεμσιταβίνη και (β) Σισπλατίνη και Γεμσιταβίνη σε ασθενείς με μη μικροκυτταρικό καρκίνο του πνεύμονα σταδίου ΙΙΙΒ / ΙV.

Degree: 2017, National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ)

 Background: Lung cancer is the most common cause of cancer and responsible for 28% of all deaths associated with cancer. Approximately 80% of lung cancer(more)

Subjects/Keywords: Μη μικροκυτταρικός καρκίνος πνεύμονα; Λιποπλατίνη; Non small cell lung cancer; Lipoplatin

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Lazarioti, F. (2017). Ανάλυση και συσχέτιση των απεικονιστικών ευρημάτων με την ανταπόκριση στη (α) Λιποπλατίνη και Γεμσιταβίνη και (β) Σισπλατίνη και Γεμσιταβίνη σε ασθενείς με μη μικροκυτταρικό καρκίνο του πνεύμονα σταδίου ΙΙΙΒ / ΙV. (Thesis). National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ). Retrieved from http://hdl.handle.net/10442/hedi/40548

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Lazarioti, Fotini. “Ανάλυση και συσχέτιση των απεικονιστικών ευρημάτων με την ανταπόκριση στη (α) Λιποπλατίνη και Γεμσιταβίνη και (β) Σισπλατίνη και Γεμσιταβίνη σε ασθενείς με μη μικροκυτταρικό καρκίνο του πνεύμονα σταδίου ΙΙΙΒ / ΙV.” 2017. Thesis, National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ). Accessed June 01, 2020. http://hdl.handle.net/10442/hedi/40548.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Lazarioti, Fotini. “Ανάλυση και συσχέτιση των απεικονιστικών ευρημάτων με την ανταπόκριση στη (α) Λιποπλατίνη και Γεμσιταβίνη και (β) Σισπλατίνη και Γεμσιταβίνη σε ασθενείς με μη μικροκυτταρικό καρκίνο του πνεύμονα σταδίου ΙΙΙΒ / ΙV.” 2017. Web. 01 Jun 2020.

Vancouver:

Lazarioti F. Ανάλυση και συσχέτιση των απεικονιστικών ευρημάτων με την ανταπόκριση στη (α) Λιποπλατίνη και Γεμσιταβίνη και (β) Σισπλατίνη και Γεμσιταβίνη σε ασθενείς με μη μικροκυτταρικό καρκίνο του πνεύμονα σταδίου ΙΙΙΒ / ΙV. [Internet] [Thesis]. National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); 2017. [cited 2020 Jun 01]. Available from: http://hdl.handle.net/10442/hedi/40548.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Lazarioti F. Ανάλυση και συσχέτιση των απεικονιστικών ευρημάτων με την ανταπόκριση στη (α) Λιποπλατίνη και Γεμσιταβίνη και (β) Σισπλατίνη και Γεμσιταβίνη σε ασθενείς με μη μικροκυτταρικό καρκίνο του πνεύμονα σταδίου ΙΙΙΒ / ΙV. [Thesis]. National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); 2017. Available from: http://hdl.handle.net/10442/hedi/40548

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

7. V. Mucchietto. PHARMACOLOGICAL AND FUNCTIONAL CHARACTERISATION OF NEURONAL NICOTINIC ACETYLCHOLINE RECEPTORS IN LUNG CANCER CELL LINES: A CHALLENGE FOR NEW THERAPEUTICAL STRATEGIES?.

Degree: 2017, Università degli Studi di Milano

Lung cancer is the leading cause of cancer-related deaths worldwide and cigarette smoking is related to 90% of all deaths due to lung cancer. Tobacco… (more)

Subjects/Keywords: nAChRs; non-small cell lung cancer; nicotine; Settore BIO/14 - Farmacologia

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Mucchietto, V. (2017). PHARMACOLOGICAL AND FUNCTIONAL CHARACTERISATION OF NEURONAL NICOTINIC ACETYLCHOLINE RECEPTORS IN LUNG CANCER CELL LINES: A CHALLENGE FOR NEW THERAPEUTICAL STRATEGIES?. (Thesis). Università degli Studi di Milano. Retrieved from http://hdl.handle.net/2434/468255

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Mucchietto, V.. “PHARMACOLOGICAL AND FUNCTIONAL CHARACTERISATION OF NEURONAL NICOTINIC ACETYLCHOLINE RECEPTORS IN LUNG CANCER CELL LINES: A CHALLENGE FOR NEW THERAPEUTICAL STRATEGIES?.” 2017. Thesis, Università degli Studi di Milano. Accessed June 01, 2020. http://hdl.handle.net/2434/468255.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Mucchietto, V.. “PHARMACOLOGICAL AND FUNCTIONAL CHARACTERISATION OF NEURONAL NICOTINIC ACETYLCHOLINE RECEPTORS IN LUNG CANCER CELL LINES: A CHALLENGE FOR NEW THERAPEUTICAL STRATEGIES?.” 2017. Web. 01 Jun 2020.

Vancouver:

Mucchietto V. PHARMACOLOGICAL AND FUNCTIONAL CHARACTERISATION OF NEURONAL NICOTINIC ACETYLCHOLINE RECEPTORS IN LUNG CANCER CELL LINES: A CHALLENGE FOR NEW THERAPEUTICAL STRATEGIES?. [Internet] [Thesis]. Università degli Studi di Milano; 2017. [cited 2020 Jun 01]. Available from: http://hdl.handle.net/2434/468255.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Mucchietto V. PHARMACOLOGICAL AND FUNCTIONAL CHARACTERISATION OF NEURONAL NICOTINIC ACETYLCHOLINE RECEPTORS IN LUNG CANCER CELL LINES: A CHALLENGE FOR NEW THERAPEUTICAL STRATEGIES?. [Thesis]. Università degli Studi di Milano; 2017. Available from: http://hdl.handle.net/2434/468255

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Edinburgh

8. Kouverianou, Eleni. Galectin-3 regulation of non small cell lung cancer growth.

Degree: PhD, 2014, University of Edinburgh

 Galectin-3 is a β-galactoside binding lectin expressed in tumour cells and macrophages and has been associated with increased malignancy in a variety of cancers. Previous… (more)

Subjects/Keywords: 616.99; Galectin-3; non small cell lung cancer; tumour associated macrophages

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Kouverianou, E. (2014). Galectin-3 regulation of non small cell lung cancer growth. (Doctoral Dissertation). University of Edinburgh. Retrieved from http://hdl.handle.net/1842/17891

Chicago Manual of Style (16th Edition):

Kouverianou, Eleni. “Galectin-3 regulation of non small cell lung cancer growth.” 2014. Doctoral Dissertation, University of Edinburgh. Accessed June 01, 2020. http://hdl.handle.net/1842/17891.

MLA Handbook (7th Edition):

Kouverianou, Eleni. “Galectin-3 regulation of non small cell lung cancer growth.” 2014. Web. 01 Jun 2020.

Vancouver:

Kouverianou E. Galectin-3 regulation of non small cell lung cancer growth. [Internet] [Doctoral dissertation]. University of Edinburgh; 2014. [cited 2020 Jun 01]. Available from: http://hdl.handle.net/1842/17891.

Council of Science Editors:

Kouverianou E. Galectin-3 regulation of non small cell lung cancer growth. [Doctoral Dissertation]. University of Edinburgh; 2014. Available from: http://hdl.handle.net/1842/17891


University of Sydney

9. Harris, Benjamin. Towards the platinum standard: investigating systemic inflammation to optimise platinum-based doublet chemotherapy in non-small cell lung cancer .

Degree: 2018, University of Sydney

Lung cancer is a leading cause of cancer-related mortality and non-small cell lung cancer (NSCLC) is the most common subtype. Gold standard first-line treatment for… (more)

Subjects/Keywords: biostatistics,chemotherapy; pharmacokinetics; inflammation; carboplatin; non-small cell lung cancer; chemotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Harris, B. (2018). Towards the platinum standard: investigating systemic inflammation to optimise platinum-based doublet chemotherapy in non-small cell lung cancer . (Thesis). University of Sydney. Retrieved from http://hdl.handle.net/2123/20833

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Harris, Benjamin. “Towards the platinum standard: investigating systemic inflammation to optimise platinum-based doublet chemotherapy in non-small cell lung cancer .” 2018. Thesis, University of Sydney. Accessed June 01, 2020. http://hdl.handle.net/2123/20833.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Harris, Benjamin. “Towards the platinum standard: investigating systemic inflammation to optimise platinum-based doublet chemotherapy in non-small cell lung cancer .” 2018. Web. 01 Jun 2020.

Vancouver:

Harris B. Towards the platinum standard: investigating systemic inflammation to optimise platinum-based doublet chemotherapy in non-small cell lung cancer . [Internet] [Thesis]. University of Sydney; 2018. [cited 2020 Jun 01]. Available from: http://hdl.handle.net/2123/20833.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Harris B. Towards the platinum standard: investigating systemic inflammation to optimise platinum-based doublet chemotherapy in non-small cell lung cancer . [Thesis]. University of Sydney; 2018. Available from: http://hdl.handle.net/2123/20833

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Uppsala University

10. Mattsson, Johanna. Genetic heterogeneity of EGFR and KRAS mutations in primary tumor tissue from non-small cell lung cancer patients.

Degree: Medical Biochemistry and Microbiology, 2011, Uppsala University

  Activated epidermal growth factor receptor (EGFR) and Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations characterize molecular subgroups of non-small cell lung cancer (NSCLC)… (more)

Subjects/Keywords: Non-small cell lung cancer; KRAS; EGFR; heterogeneity; mutation

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Mattsson, J. (2011). Genetic heterogeneity of EGFR and KRAS mutations in primary tumor tissue from non-small cell lung cancer patients. (Thesis). Uppsala University. Retrieved from http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-159359

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Mattsson, Johanna. “Genetic heterogeneity of EGFR and KRAS mutations in primary tumor tissue from non-small cell lung cancer patients.” 2011. Thesis, Uppsala University. Accessed June 01, 2020. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-159359.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Mattsson, Johanna. “Genetic heterogeneity of EGFR and KRAS mutations in primary tumor tissue from non-small cell lung cancer patients.” 2011. Web. 01 Jun 2020.

Vancouver:

Mattsson J. Genetic heterogeneity of EGFR and KRAS mutations in primary tumor tissue from non-small cell lung cancer patients. [Internet] [Thesis]. Uppsala University; 2011. [cited 2020 Jun 01]. Available from: http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-159359.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Mattsson J. Genetic heterogeneity of EGFR and KRAS mutations in primary tumor tissue from non-small cell lung cancer patients. [Thesis]. Uppsala University; 2011. Available from: http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-159359

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Kansas State University

11. Kalubowilage, Madumali. Liquid biopsies of solid tumors: non-small-cell lung and pancreatic cancer.

Degree: PhD, Department of Chemistry, 2017, Kansas State University

Cancer is a group of diseases that are characterized by uncontrolled growth and spread of cells. In order to treat cancer successfully, it is important… (more)

Subjects/Keywords: liquid biopsy; pancreatic cancer; non small cell lung cancer; fluorescence detection; nanobiosensor; cancer detection

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Kalubowilage, M. (2017). Liquid biopsies of solid tumors: non-small-cell lung and pancreatic cancer. (Doctoral Dissertation). Kansas State University. Retrieved from http://hdl.handle.net/2097/35385

Chicago Manual of Style (16th Edition):

Kalubowilage, Madumali. “Liquid biopsies of solid tumors: non-small-cell lung and pancreatic cancer.” 2017. Doctoral Dissertation, Kansas State University. Accessed June 01, 2020. http://hdl.handle.net/2097/35385.

MLA Handbook (7th Edition):

Kalubowilage, Madumali. “Liquid biopsies of solid tumors: non-small-cell lung and pancreatic cancer.” 2017. Web. 01 Jun 2020.

Vancouver:

Kalubowilage M. Liquid biopsies of solid tumors: non-small-cell lung and pancreatic cancer. [Internet] [Doctoral dissertation]. Kansas State University; 2017. [cited 2020 Jun 01]. Available from: http://hdl.handle.net/2097/35385.

Council of Science Editors:

Kalubowilage M. Liquid biopsies of solid tumors: non-small-cell lung and pancreatic cancer. [Doctoral Dissertation]. Kansas State University; 2017. Available from: http://hdl.handle.net/2097/35385


University of Louisville

12. Whitt, Aaron. Paraoxonase 2 is critical for non-small cell lung carcinoma proliferation.

Degree: MS, 2019, University of Louisville

Non-small cell lung carcinoma (NSCLC) comprises 85% of lung cancer diagnoses and is plagued by drug resistance. Thus, elucidating the underlying mechanisms of NSCLC… (more)

Subjects/Keywords: Paraoxonase 2; PON2; cancer; non-small cell lung carcinoma; NSCLC; Cancer Biology; Molecular Biology; Pharmacology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Whitt, A. (2019). Paraoxonase 2 is critical for non-small cell lung carcinoma proliferation. (Masters Thesis). University of Louisville. Retrieved from 10.18297/etd/3236 ; https://ir.library.louisville.edu/etd/3236

Chicago Manual of Style (16th Edition):

Whitt, Aaron. “Paraoxonase 2 is critical for non-small cell lung carcinoma proliferation.” 2019. Masters Thesis, University of Louisville. Accessed June 01, 2020. 10.18297/etd/3236 ; https://ir.library.louisville.edu/etd/3236.

MLA Handbook (7th Edition):

Whitt, Aaron. “Paraoxonase 2 is critical for non-small cell lung carcinoma proliferation.” 2019. Web. 01 Jun 2020.

Vancouver:

Whitt A. Paraoxonase 2 is critical for non-small cell lung carcinoma proliferation. [Internet] [Masters thesis]. University of Louisville; 2019. [cited 2020 Jun 01]. Available from: 10.18297/etd/3236 ; https://ir.library.louisville.edu/etd/3236.

Council of Science Editors:

Whitt A. Paraoxonase 2 is critical for non-small cell lung carcinoma proliferation. [Masters Thesis]. University of Louisville; 2019. Available from: 10.18297/etd/3236 ; https://ir.library.louisville.edu/etd/3236


University of Wolverhampton

13. Butcher, Kate. In vitro and in vivo investigation of the anticancer activity and molecular mechanisms of disulfiram in non-small cell lung cancer.

Degree: PhD, 2019, University of Wolverhampton

 Background: This study aims to repurpose disulfiram (DS), a drug used to treat alcohol dependence, into an effective treatment for non-small cell lung cancer (NSCLC).… (more)

Subjects/Keywords: disulfiram; non-small cell lung cancer; chemoresistance; cancer stem cells; hypoxia; NF-κB

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Butcher, K. (2019). In vitro and in vivo investigation of the anticancer activity and molecular mechanisms of disulfiram in non-small cell lung cancer. (Doctoral Dissertation). University of Wolverhampton. Retrieved from http://hdl.handle.net/2436/623026

Chicago Manual of Style (16th Edition):

Butcher, Kate. “In vitro and in vivo investigation of the anticancer activity and molecular mechanisms of disulfiram in non-small cell lung cancer.” 2019. Doctoral Dissertation, University of Wolverhampton. Accessed June 01, 2020. http://hdl.handle.net/2436/623026.

MLA Handbook (7th Edition):

Butcher, Kate. “In vitro and in vivo investigation of the anticancer activity and molecular mechanisms of disulfiram in non-small cell lung cancer.” 2019. Web. 01 Jun 2020.

Vancouver:

Butcher K. In vitro and in vivo investigation of the anticancer activity and molecular mechanisms of disulfiram in non-small cell lung cancer. [Internet] [Doctoral dissertation]. University of Wolverhampton; 2019. [cited 2020 Jun 01]. Available from: http://hdl.handle.net/2436/623026.

Council of Science Editors:

Butcher K. In vitro and in vivo investigation of the anticancer activity and molecular mechanisms of disulfiram in non-small cell lung cancer. [Doctoral Dissertation]. University of Wolverhampton; 2019. Available from: http://hdl.handle.net/2436/623026


University of Akron

14. DeBord, Michael. Synthesis, characterization, and anti-cancer structure-activity relationship studies of imidazolium salts.

Degree: PhD, Chemistry, 2017, University of Akron

 Imidazolium salts have received significant attention for their anti-cancer properties. Human cancer cell lines have been treated with hundreds of imidazolium salts and many have… (more)

Subjects/Keywords: Chemistry; Biochemistry; Medicine; imidazolium salt; anti-cancer; anti-tumor; lung cancer; cyclodextrin; non-small cell lung cancer; naphthalene; quinoline

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

DeBord, M. (2017). Synthesis, characterization, and anti-cancer structure-activity relationship studies of imidazolium salts. (Doctoral Dissertation). University of Akron. Retrieved from http://rave.ohiolink.edu/etdc/view?acc_num=akron1489414733025495

Chicago Manual of Style (16th Edition):

DeBord, Michael. “Synthesis, characterization, and anti-cancer structure-activity relationship studies of imidazolium salts.” 2017. Doctoral Dissertation, University of Akron. Accessed June 01, 2020. http://rave.ohiolink.edu/etdc/view?acc_num=akron1489414733025495.

MLA Handbook (7th Edition):

DeBord, Michael. “Synthesis, characterization, and anti-cancer structure-activity relationship studies of imidazolium salts.” 2017. Web. 01 Jun 2020.

Vancouver:

DeBord M. Synthesis, characterization, and anti-cancer structure-activity relationship studies of imidazolium salts. [Internet] [Doctoral dissertation]. University of Akron; 2017. [cited 2020 Jun 01]. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=akron1489414733025495.

Council of Science Editors:

DeBord M. Synthesis, characterization, and anti-cancer structure-activity relationship studies of imidazolium salts. [Doctoral Dissertation]. University of Akron; 2017. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=akron1489414733025495


University of Lund

15. Karlsson, Anna F. Genomic characterization of non-small cell lung cancer - clinical and molecular implications.

Degree: 2018, University of Lund

Lung cancer accounts for 1.6 million cancers annually and 1.3 million deaths per year make the disease the deadliest type of cancer. Smoking is the… (more)

Subjects/Keywords: Cancer and Oncology; Lung cancer; histology; non-small cell lung cancer; gene expression; gene fusion; Methylation

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Karlsson, A. F. (2018). Genomic characterization of non-small cell lung cancer - clinical and molecular implications. (Doctoral Dissertation). University of Lund. Retrieved from https://lup.lub.lu.se/record/a2a0a480-966e-470e-838b-8643a20dbcf5 ; https://portal.research.lu.se/ws/files/51459080/Thesis_Anna_F_Karlsson_LUCRIS.pdf

Chicago Manual of Style (16th Edition):

Karlsson, Anna F. “Genomic characterization of non-small cell lung cancer - clinical and molecular implications.” 2018. Doctoral Dissertation, University of Lund. Accessed June 01, 2020. https://lup.lub.lu.se/record/a2a0a480-966e-470e-838b-8643a20dbcf5 ; https://portal.research.lu.se/ws/files/51459080/Thesis_Anna_F_Karlsson_LUCRIS.pdf.

MLA Handbook (7th Edition):

Karlsson, Anna F. “Genomic characterization of non-small cell lung cancer - clinical and molecular implications.” 2018. Web. 01 Jun 2020.

Vancouver:

Karlsson AF. Genomic characterization of non-small cell lung cancer - clinical and molecular implications. [Internet] [Doctoral dissertation]. University of Lund; 2018. [cited 2020 Jun 01]. Available from: https://lup.lub.lu.se/record/a2a0a480-966e-470e-838b-8643a20dbcf5 ; https://portal.research.lu.se/ws/files/51459080/Thesis_Anna_F_Karlsson_LUCRIS.pdf.

Council of Science Editors:

Karlsson AF. Genomic characterization of non-small cell lung cancer - clinical and molecular implications. [Doctoral Dissertation]. University of Lund; 2018. Available from: https://lup.lub.lu.se/record/a2a0a480-966e-470e-838b-8643a20dbcf5 ; https://portal.research.lu.se/ws/files/51459080/Thesis_Anna_F_Karlsson_LUCRIS.pdf

16. Charrier, Mélinda. Caractérisation phénotypique et fonctionnelle de sous-populations Natural Killer (NK) chez des patients atteints d’un cancer bronchique non à petites cellules et impact d’une vaccination avec des exosomes de cellules dendritiques (Dex) autologues : Phenotypic and functional characterization in subpopulations of Natural Killer cells in patients with non-small cell lung cancer and impact of vaccination with autologus dendritic cell-derived exosomes (Dex).

Degree: Docteur es, Sciences de la vie et de la santé, 2016, Université Paris-Saclay (ComUE)

Depuis peu, l’immunothérapie a émergé comme une nouvelle stratégie chez les patients atteint de Cancer Bronchique Non à Petites Cellules (CBNPC), confirmant ainsi le rôle… (more)

Subjects/Keywords: Cancer; Immunologie; Cellules NK; NKp30; Cancer Bronchique Non à Petites cellules; Cancer; Immunology; NK cells; NKp30; Non Small Cell lung cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Charrier, M. (2016). Caractérisation phénotypique et fonctionnelle de sous-populations Natural Killer (NK) chez des patients atteints d’un cancer bronchique non à petites cellules et impact d’une vaccination avec des exosomes de cellules dendritiques (Dex) autologues : Phenotypic and functional characterization in subpopulations of Natural Killer cells in patients with non-small cell lung cancer and impact of vaccination with autologus dendritic cell-derived exosomes (Dex). (Doctoral Dissertation). Université Paris-Saclay (ComUE). Retrieved from http://www.theses.fr/2016SACLS438

Chicago Manual of Style (16th Edition):

Charrier, Mélinda. “Caractérisation phénotypique et fonctionnelle de sous-populations Natural Killer (NK) chez des patients atteints d’un cancer bronchique non à petites cellules et impact d’une vaccination avec des exosomes de cellules dendritiques (Dex) autologues : Phenotypic and functional characterization in subpopulations of Natural Killer cells in patients with non-small cell lung cancer and impact of vaccination with autologus dendritic cell-derived exosomes (Dex).” 2016. Doctoral Dissertation, Université Paris-Saclay (ComUE). Accessed June 01, 2020. http://www.theses.fr/2016SACLS438.

MLA Handbook (7th Edition):

Charrier, Mélinda. “Caractérisation phénotypique et fonctionnelle de sous-populations Natural Killer (NK) chez des patients atteints d’un cancer bronchique non à petites cellules et impact d’une vaccination avec des exosomes de cellules dendritiques (Dex) autologues : Phenotypic and functional characterization in subpopulations of Natural Killer cells in patients with non-small cell lung cancer and impact of vaccination with autologus dendritic cell-derived exosomes (Dex).” 2016. Web. 01 Jun 2020.

Vancouver:

Charrier M. Caractérisation phénotypique et fonctionnelle de sous-populations Natural Killer (NK) chez des patients atteints d’un cancer bronchique non à petites cellules et impact d’une vaccination avec des exosomes de cellules dendritiques (Dex) autologues : Phenotypic and functional characterization in subpopulations of Natural Killer cells in patients with non-small cell lung cancer and impact of vaccination with autologus dendritic cell-derived exosomes (Dex). [Internet] [Doctoral dissertation]. Université Paris-Saclay (ComUE); 2016. [cited 2020 Jun 01]. Available from: http://www.theses.fr/2016SACLS438.

Council of Science Editors:

Charrier M. Caractérisation phénotypique et fonctionnelle de sous-populations Natural Killer (NK) chez des patients atteints d’un cancer bronchique non à petites cellules et impact d’une vaccination avec des exosomes de cellules dendritiques (Dex) autologues : Phenotypic and functional characterization in subpopulations of Natural Killer cells in patients with non-small cell lung cancer and impact of vaccination with autologus dendritic cell-derived exosomes (Dex). [Doctoral Dissertation]. Université Paris-Saclay (ComUE); 2016. Available from: http://www.theses.fr/2016SACLS438


University of Victoria

17. Mader, Joanna E. Flattening Filter Free photon beams for treatment of early-stage lung cancer: an investigation of peripheral dose.

Degree: Department of Physics and Astronomy, 2014, University of Victoria

 The purpose of this thesis was to evaluate and compare the peripheral dose associated with VMAT lung SABR treatments for 10X, 6X, and 10X-FFF beams.… (more)

Subjects/Keywords: Flattening Filter Free; Radiation Therapy; Radiotherapy; Lung Cancer; Non-Small Cell Lung Carcinoma; Peripheral Dose; VMAT Lung SABR

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Mader, J. E. (2014). Flattening Filter Free photon beams for treatment of early-stage lung cancer: an investigation of peripheral dose. (Masters Thesis). University of Victoria. Retrieved from http://hdl.handle.net/1828/5806

Chicago Manual of Style (16th Edition):

Mader, Joanna E. “Flattening Filter Free photon beams for treatment of early-stage lung cancer: an investigation of peripheral dose.” 2014. Masters Thesis, University of Victoria. Accessed June 01, 2020. http://hdl.handle.net/1828/5806.

MLA Handbook (7th Edition):

Mader, Joanna E. “Flattening Filter Free photon beams for treatment of early-stage lung cancer: an investigation of peripheral dose.” 2014. Web. 01 Jun 2020.

Vancouver:

Mader JE. Flattening Filter Free photon beams for treatment of early-stage lung cancer: an investigation of peripheral dose. [Internet] [Masters thesis]. University of Victoria; 2014. [cited 2020 Jun 01]. Available from: http://hdl.handle.net/1828/5806.

Council of Science Editors:

Mader JE. Flattening Filter Free photon beams for treatment of early-stage lung cancer: an investigation of peripheral dose. [Masters Thesis]. University of Victoria; 2014. Available from: http://hdl.handle.net/1828/5806


Dalhousie University

18. Kureshi, Nelofar. Personalized Medicine: Development of a Predictive Computational Model for Personalized Therapeutic Interventions.

Degree: Master of Health Informatics, Health Informatics, 2013, Dalhousie University

Lung cancer is the leading cause of cancer-related deaths among men and women. Non-Small Cell Lung Cancer (NSCLC) constitutes the most common type of lung(more)

Subjects/Keywords: Personalized medicine; Non-small cell lung cancer; Epidermal growth factor receptor; Decision support

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Kureshi, N. (2013). Personalized Medicine: Development of a Predictive Computational Model for Personalized Therapeutic Interventions. (Masters Thesis). Dalhousie University. Retrieved from http://hdl.handle.net/10222/35383

Chicago Manual of Style (16th Edition):

Kureshi, Nelofar. “Personalized Medicine: Development of a Predictive Computational Model for Personalized Therapeutic Interventions.” 2013. Masters Thesis, Dalhousie University. Accessed June 01, 2020. http://hdl.handle.net/10222/35383.

MLA Handbook (7th Edition):

Kureshi, Nelofar. “Personalized Medicine: Development of a Predictive Computational Model for Personalized Therapeutic Interventions.” 2013. Web. 01 Jun 2020.

Vancouver:

Kureshi N. Personalized Medicine: Development of a Predictive Computational Model for Personalized Therapeutic Interventions. [Internet] [Masters thesis]. Dalhousie University; 2013. [cited 2020 Jun 01]. Available from: http://hdl.handle.net/10222/35383.

Council of Science Editors:

Kureshi N. Personalized Medicine: Development of a Predictive Computational Model for Personalized Therapeutic Interventions. [Masters Thesis]. Dalhousie University; 2013. Available from: http://hdl.handle.net/10222/35383

19. Χαλίμου, Ιωάννα. Symptom documentation and tumor repopulation factors as a basis for treatment modifications in non-small cell lung cancer radiotherapy.

Degree: 2009, University of Patras

 Recent studies have suggested significant variation in radiotherapy schedules used to treat advanced NSCLC, both between different centres as well as between countries. In this… (more)

Subjects/Keywords: Radiotherapy; Non-small cell lung cancer; Advanced; 616.994 240 6; Ακτινοθεραπεία; Καρκίνος πνεύμονα

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Χαλίμου, . (2009). Symptom documentation and tumor repopulation factors as a basis for treatment modifications in non-small cell lung cancer radiotherapy. (Masters Thesis). University of Patras. Retrieved from http://nemertes.lis.upatras.gr/jspui/handle/10889/2487

Chicago Manual of Style (16th Edition):

Χαλίμου, Ιωάννα. “Symptom documentation and tumor repopulation factors as a basis for treatment modifications in non-small cell lung cancer radiotherapy.” 2009. Masters Thesis, University of Patras. Accessed June 01, 2020. http://nemertes.lis.upatras.gr/jspui/handle/10889/2487.

MLA Handbook (7th Edition):

Χαλίμου, Ιωάννα. “Symptom documentation and tumor repopulation factors as a basis for treatment modifications in non-small cell lung cancer radiotherapy.” 2009. Web. 01 Jun 2020.

Vancouver:

Χαλίμου . Symptom documentation and tumor repopulation factors as a basis for treatment modifications in non-small cell lung cancer radiotherapy. [Internet] [Masters thesis]. University of Patras; 2009. [cited 2020 Jun 01]. Available from: http://nemertes.lis.upatras.gr/jspui/handle/10889/2487.

Council of Science Editors:

Χαλίμου . Symptom documentation and tumor repopulation factors as a basis for treatment modifications in non-small cell lung cancer radiotherapy. [Masters Thesis]. University of Patras; 2009. Available from: http://nemertes.lis.upatras.gr/jspui/handle/10889/2487

20. Χαρπίδου, Ανδριανή. Έκφραση παραγόντων νεοαγγειογένεσης σε ασθενείς με μη μικροκυτταρικό καρκίνο του πνεύμονος.

Degree: 2010, Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); National and Kapodistrian University of Athens

 Εισαγωγή: Η αγγειογένεση έχει αποδειχτεί ότι είναι μία διαδικασία που σχετίζεται με την αύξηση, τον πολλαπλασιασμό και το μεταστατικό δυναμικό των καρκινικών κυττάρων. Ο κύριος… (more)

Subjects/Keywords: Μη μικροκυτταρικός καρκίνος πνεύμονα; Αγγειογένεση; Προγνωστικοί παράγοντες; Non-small cell lung cancer; Angiogenesis; Prognostic factors

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Χαρπίδου, . (2010). Έκφραση παραγόντων νεοαγγειογένεσης σε ασθενείς με μη μικροκυτταρικό καρκίνο του πνεύμονος. (Thesis). Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); National and Kapodistrian University of Athens. Retrieved from http://hdl.handle.net/10442/hedi/24323

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Χαρπίδου, Ανδριανή. “Έκφραση παραγόντων νεοαγγειογένεσης σε ασθενείς με μη μικροκυτταρικό καρκίνο του πνεύμονος.” 2010. Thesis, Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); National and Kapodistrian University of Athens. Accessed June 01, 2020. http://hdl.handle.net/10442/hedi/24323.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Χαρπίδου, Ανδριανή. “Έκφραση παραγόντων νεοαγγειογένεσης σε ασθενείς με μη μικροκυτταρικό καρκίνο του πνεύμονος.” 2010. Web. 01 Jun 2020.

Vancouver:

Χαρπίδου . Έκφραση παραγόντων νεοαγγειογένεσης σε ασθενείς με μη μικροκυτταρικό καρκίνο του πνεύμονος. [Internet] [Thesis]. Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); National and Kapodistrian University of Athens; 2010. [cited 2020 Jun 01]. Available from: http://hdl.handle.net/10442/hedi/24323.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Χαρπίδου . Έκφραση παραγόντων νεοαγγειογένεσης σε ασθενείς με μη μικροκυτταρικό καρκίνο του πνεύμονος. [Thesis]. Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); National and Kapodistrian University of Athens; 2010. Available from: http://hdl.handle.net/10442/hedi/24323

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

21. Koufos, Nikolaos. Αγγειογενετικές και ανοσολογικές παραμέτροι στον ιστό μη μικροκυτταρικού καρκίνου του πνεύμονα πριν και μετά τη θεραπεία.

Degree: 2015, National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ)

Purpose The expression of various angiogenic factors was assessed in tumour samplesof patients with stage III NSCLC before treatment and further analyzed in relation toresponse… (more)

Subjects/Keywords: Καρκίνος πνεύμονα, Μη μικροκυτταρικός; Αγγειογένεση όγκου; Lung cancer, Non small cell; Tumor angiogenesis

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Koufos, N. (2015). Αγγειογενετικές και ανοσολογικές παραμέτροι στον ιστό μη μικροκυτταρικού καρκίνου του πνεύμονα πριν και μετά τη θεραπεία. (Thesis). National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ). Retrieved from http://hdl.handle.net/10442/hedi/35956

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Koufos, Nikolaos. “Αγγειογενετικές και ανοσολογικές παραμέτροι στον ιστό μη μικροκυτταρικού καρκίνου του πνεύμονα πριν και μετά τη θεραπεία.” 2015. Thesis, National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ). Accessed June 01, 2020. http://hdl.handle.net/10442/hedi/35956.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Koufos, Nikolaos. “Αγγειογενετικές και ανοσολογικές παραμέτροι στον ιστό μη μικροκυτταρικού καρκίνου του πνεύμονα πριν και μετά τη θεραπεία.” 2015. Web. 01 Jun 2020.

Vancouver:

Koufos N. Αγγειογενετικές και ανοσολογικές παραμέτροι στον ιστό μη μικροκυτταρικού καρκίνου του πνεύμονα πριν και μετά τη θεραπεία. [Internet] [Thesis]. National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); 2015. [cited 2020 Jun 01]. Available from: http://hdl.handle.net/10442/hedi/35956.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Koufos N. Αγγειογενετικές και ανοσολογικές παραμέτροι στον ιστό μη μικροκυτταρικού καρκίνου του πνεύμονα πριν και μετά τη θεραπεία. [Thesis]. National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); 2015. Available from: http://hdl.handle.net/10442/hedi/35956

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


The Ohio State University

22. Wang, Yu-Chieh. Exploitation and Mechanistic Validation of Drug-combination Strategies to Overcome EGFR-inhibitor resistance in NSCLC cells.

Degree: PhD, Pharmacy, 2008, The Ohio State University

 Pre-existing and acquired resistance to epidermal growth factor receptor (EGFR) inhibitors limits their clinical usefulness in patients with advanced non-small cell lung cancer (NSCLC). In… (more)

Subjects/Keywords: Oncology; non-small cell lung cancer; EGFR inhibitor; HDAC inhibitor; Akt; ER stress; NR4A1

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Wang, Y. (2008). Exploitation and Mechanistic Validation of Drug-combination Strategies to Overcome EGFR-inhibitor resistance in NSCLC cells. (Doctoral Dissertation). The Ohio State University. Retrieved from http://rave.ohiolink.edu/etdc/view?acc_num=osu1226515990

Chicago Manual of Style (16th Edition):

Wang, Yu-Chieh. “Exploitation and Mechanistic Validation of Drug-combination Strategies to Overcome EGFR-inhibitor resistance in NSCLC cells.” 2008. Doctoral Dissertation, The Ohio State University. Accessed June 01, 2020. http://rave.ohiolink.edu/etdc/view?acc_num=osu1226515990.

MLA Handbook (7th Edition):

Wang, Yu-Chieh. “Exploitation and Mechanistic Validation of Drug-combination Strategies to Overcome EGFR-inhibitor resistance in NSCLC cells.” 2008. Web. 01 Jun 2020.

Vancouver:

Wang Y. Exploitation and Mechanistic Validation of Drug-combination Strategies to Overcome EGFR-inhibitor resistance in NSCLC cells. [Internet] [Doctoral dissertation]. The Ohio State University; 2008. [cited 2020 Jun 01]. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=osu1226515990.

Council of Science Editors:

Wang Y. Exploitation and Mechanistic Validation of Drug-combination Strategies to Overcome EGFR-inhibitor resistance in NSCLC cells. [Doctoral Dissertation]. The Ohio State University; 2008. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=osu1226515990

23. 朝永, 七枝. Analysis of Intratumor Heterogeneity of EGFR Mutations in Mixed Type Lung Adenocarcinoma : 混合型肺腺癌におけるEGFR遺伝子変異のheterogeneityについての解析.

Degree: 博士(医学), 2014, Nagasaki University / 長崎大学

 Background: Epidermal growth factor receptor mutations are predictive of the success of EGFR tyrosine kinase inhibitor treatment in patients with advanced non-small-cell lung cancer. As… (more)

Subjects/Keywords: EGFR mutations; Heterogeneity; Mixed type adenocarcinoma; Non-small-cell lung cancer; Smoking

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

朝永, . (2014). Analysis of Intratumor Heterogeneity of EGFR Mutations in Mixed Type Lung Adenocarcinoma : 混合型肺腺癌におけるEGFR遺伝子変異のheterogeneityについての解析. (Thesis). Nagasaki University / 長崎大学. Retrieved from http://hdl.handle.net/10069/35904

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

朝永, 七枝. “Analysis of Intratumor Heterogeneity of EGFR Mutations in Mixed Type Lung Adenocarcinoma : 混合型肺腺癌におけるEGFR遺伝子変異のheterogeneityについての解析.” 2014. Thesis, Nagasaki University / 長崎大学. Accessed June 01, 2020. http://hdl.handle.net/10069/35904.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

朝永, 七枝. “Analysis of Intratumor Heterogeneity of EGFR Mutations in Mixed Type Lung Adenocarcinoma : 混合型肺腺癌におけるEGFR遺伝子変異のheterogeneityについての解析.” 2014. Web. 01 Jun 2020.

Vancouver:

朝永 . Analysis of Intratumor Heterogeneity of EGFR Mutations in Mixed Type Lung Adenocarcinoma : 混合型肺腺癌におけるEGFR遺伝子変異のheterogeneityについての解析. [Internet] [Thesis]. Nagasaki University / 長崎大学; 2014. [cited 2020 Jun 01]. Available from: http://hdl.handle.net/10069/35904.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

朝永 . Analysis of Intratumor Heterogeneity of EGFR Mutations in Mixed Type Lung Adenocarcinoma : 混合型肺腺癌におけるEGFR遺伝子変異のheterogeneityについての解析. [Thesis]. Nagasaki University / 長崎大学; 2014. Available from: http://hdl.handle.net/10069/35904

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

24. 富永, 哲郎. Epidermal growth factor signals regulate dihydropyrimidine dehydrogenase expression in EGFR-mutated non-small-cell lung cancer : EGFR変異型非小細胞肺癌におけるEGFシグナルのDPD発現調整.

Degree: 博士(医学), 2016, Nagasaki University / 長崎大学

 Background: It has been shown that epidermal growth factor receptor (EGFR) mutation status is associated with 5-fluorouracil (5-FU) sensitivity in non-small-cell lung cancer (NSCLC). However,… (more)

Subjects/Keywords: Non-small-cell lung cancer; Sp1; Dihydropyrimidine dehydrogenase; Epidermal growth factor receptor mutation; 5-fluorouracil

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

富永, . (2016). Epidermal growth factor signals regulate dihydropyrimidine dehydrogenase expression in EGFR-mutated non-small-cell lung cancer : EGFR変異型非小細胞肺癌におけるEGFシグナルのDPD発現調整. (Thesis). Nagasaki University / 長崎大学. Retrieved from http://hdl.handle.net/10069/36831

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

富永, 哲郎. “Epidermal growth factor signals regulate dihydropyrimidine dehydrogenase expression in EGFR-mutated non-small-cell lung cancer : EGFR変異型非小細胞肺癌におけるEGFシグナルのDPD発現調整.” 2016. Thesis, Nagasaki University / 長崎大学. Accessed June 01, 2020. http://hdl.handle.net/10069/36831.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

富永, 哲郎. “Epidermal growth factor signals regulate dihydropyrimidine dehydrogenase expression in EGFR-mutated non-small-cell lung cancer : EGFR変異型非小細胞肺癌におけるEGFシグナルのDPD発現調整.” 2016. Web. 01 Jun 2020.

Vancouver:

富永 . Epidermal growth factor signals regulate dihydropyrimidine dehydrogenase expression in EGFR-mutated non-small-cell lung cancer : EGFR変異型非小細胞肺癌におけるEGFシグナルのDPD発現調整. [Internet] [Thesis]. Nagasaki University / 長崎大学; 2016. [cited 2020 Jun 01]. Available from: http://hdl.handle.net/10069/36831.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

富永 . Epidermal growth factor signals regulate dihydropyrimidine dehydrogenase expression in EGFR-mutated non-small-cell lung cancer : EGFR変異型非小細胞肺癌におけるEGFシグナルのDPD発現調整. [Thesis]. Nagasaki University / 長崎大学; 2016. Available from: http://hdl.handle.net/10069/36831

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

25. 溝口, 孝輔. Pharmacokinetic parameters of gefitinib predict efficacy
and toxicity in patients with advanced non‐small cell lung cancer harboring EGFR mutations : ゲフィチニブの薬物動態パラメーターと無増悪生存期間・有害事象との相関.

Degree: 博士(医学), 2016, Nagasaki University / 長崎大学

 Purpose: The relationship between plasma concentration and antitumor activity of gefitinib was assessed in patients with advanced non-small cell lung cancer (NSCLC) harboring epidermal growth… (more)

Subjects/Keywords: Chemotherapy; EGFR mutations; Elimination half-life; Gefitinib; Non-small cell lung cancer; Pharmacokinetics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

溝口, . (2016). Pharmacokinetic parameters of gefitinib predict efficacy
and toxicity in patients with advanced non‐small cell lung cancer harboring EGFR mutations : ゲフィチニブの薬物動態パラメーターと無増悪生存期間・有害事象との相関. (Thesis). Nagasaki University / 長崎大学. Retrieved from http://hdl.handle.net/10069/37043

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

溝口, 孝輔. “Pharmacokinetic parameters of gefitinib predict efficacy
and toxicity in patients with advanced non‐small cell lung cancer harboring EGFR mutations : ゲフィチニブの薬物動態パラメーターと無増悪生存期間・有害事象との相関.” 2016. Thesis, Nagasaki University / 長崎大学. Accessed June 01, 2020. http://hdl.handle.net/10069/37043.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

溝口, 孝輔. “Pharmacokinetic parameters of gefitinib predict efficacy
and toxicity in patients with advanced non‐small cell lung cancer harboring EGFR mutations : ゲフィチニブの薬物動態パラメーターと無増悪生存期間・有害事象との相関.” 2016. Web. 01 Jun 2020.

Vancouver:

溝口 . Pharmacokinetic parameters of gefitinib predict efficacy
and toxicity in patients with advanced non‐small cell lung cancer harboring EGFR mutations : ゲフィチニブの薬物動態パラメーターと無増悪生存期間・有害事象との相関. [Internet] [Thesis]. Nagasaki University / 長崎大学; 2016. [cited 2020 Jun 01]. Available from: http://hdl.handle.net/10069/37043.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

溝口 . Pharmacokinetic parameters of gefitinib predict efficacy
and toxicity in patients with advanced non‐small cell lung cancer harboring EGFR mutations : ゲフィチニブの薬物動態パラメーターと無増悪生存期間・有害事象との相関. [Thesis]. Nagasaki University / 長崎大学; 2016. Available from: http://hdl.handle.net/10069/37043

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

26. Inoue, Yusuke. Clinical significance of PD-L1 and PD-L2 copy number gains in non-small-cell lung cancer : 非小細胞肺がんにおけるPD-L1、PD-L2遺伝子コピー数増加の臨床的意義.

Degree: 博士(医学), 2017, Hamamatsu University School of Medicine / 浜松医科大学

New reliable biomarkers are needed to predict the response to immune checkpoint inhibitors against programmed death‑1 (PD‑1) and its ligand (PD‑L1), because PD‑L1 expression on… (more)

Subjects/Keywords: PD‑L1; PD‑L2; amplification; copy number; non‑small‑cell lung cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Inoue, Y. (2017). Clinical significance of PD-L1 and PD-L2 copy number gains in non-small-cell lung cancer : 非小細胞肺がんにおけるPD-L1、PD-L2遺伝子コピー数増加の臨床的意義. (Thesis). Hamamatsu University School of Medicine / 浜松医科大学. Retrieved from http://hdl.handle.net/10271/3219

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Inoue, Yusuke. “Clinical significance of PD-L1 and PD-L2 copy number gains in non-small-cell lung cancer : 非小細胞肺がんにおけるPD-L1、PD-L2遺伝子コピー数増加の臨床的意義.” 2017. Thesis, Hamamatsu University School of Medicine / 浜松医科大学. Accessed June 01, 2020. http://hdl.handle.net/10271/3219.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Inoue, Yusuke. “Clinical significance of PD-L1 and PD-L2 copy number gains in non-small-cell lung cancer : 非小細胞肺がんにおけるPD-L1、PD-L2遺伝子コピー数増加の臨床的意義.” 2017. Web. 01 Jun 2020.

Vancouver:

Inoue Y. Clinical significance of PD-L1 and PD-L2 copy number gains in non-small-cell lung cancer : 非小細胞肺がんにおけるPD-L1、PD-L2遺伝子コピー数増加の臨床的意義. [Internet] [Thesis]. Hamamatsu University School of Medicine / 浜松医科大学; 2017. [cited 2020 Jun 01]. Available from: http://hdl.handle.net/10271/3219.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Inoue Y. Clinical significance of PD-L1 and PD-L2 copy number gains in non-small-cell lung cancer : 非小細胞肺がんにおけるPD-L1、PD-L2遺伝子コピー数増加の臨床的意義. [Thesis]. Hamamatsu University School of Medicine / 浜松医科大学; 2017. Available from: http://hdl.handle.net/10271/3219

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

27. 정, 금숙. Outcome and prognostic factors of palliative chemotherapy for non-small cell lung cancer patients at single institution: 2002-2011.

Degree: 2014, Ajou University

 This study is related to general and clinicopathologic characteristics of non-small cell lung cancer patients who received palliative chemotherapy, overall survival, and factors that affect… (more)

Subjects/Keywords: 고식적항암화학요법; 비소세포폐암; 생존율; 예후인자; palliative chemotherapy; non-small cell lung cancer; survival; prognostic factors

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

정, . (2014). Outcome and prognostic factors of palliative chemotherapy for non-small cell lung cancer patients at single institution: 2002-2011. (Thesis). Ajou University. Retrieved from http://repository.ajou.ac.kr/handle/201003/10829 ; http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000016803

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

정, 금숙. “Outcome and prognostic factors of palliative chemotherapy for non-small cell lung cancer patients at single institution: 2002-2011.” 2014. Thesis, Ajou University. Accessed June 01, 2020. http://repository.ajou.ac.kr/handle/201003/10829 ; http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000016803.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

정, 금숙. “Outcome and prognostic factors of palliative chemotherapy for non-small cell lung cancer patients at single institution: 2002-2011.” 2014. Web. 01 Jun 2020.

Vancouver:

정 . Outcome and prognostic factors of palliative chemotherapy for non-small cell lung cancer patients at single institution: 2002-2011. [Internet] [Thesis]. Ajou University; 2014. [cited 2020 Jun 01]. Available from: http://repository.ajou.ac.kr/handle/201003/10829 ; http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000016803.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

정 . Outcome and prognostic factors of palliative chemotherapy for non-small cell lung cancer patients at single institution: 2002-2011. [Thesis]. Ajou University; 2014. Available from: http://repository.ajou.ac.kr/handle/201003/10829 ; http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000016803

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Univerzitet u Beogradu

28. Marić, Dragana M., 1972-. Procena kvaliteta života bolesnika sa završnim stadijumima hronične opstruktivne bolesti pluća i nemikrocelularnog karcinoma pluća.

Degree: Medicinski fakultet, 2016, Univerzitet u Beogradu

interna medicina - pulmologija / Internal medicine - pulmonology

Glavni cilj palijativnog zbrinjavnja je poboljšanje kvaliteta života (KŽ) bolesnika u bilo kom stadijumu bolesti koja… (more)

Subjects/Keywords: quality of life; palliative care; end-of-life care; COPD; non-small cell lung cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Marić, Dragana M., 1. (2016). Procena kvaliteta života bolesnika sa završnim stadijumima hronične opstruktivne bolesti pluća i nemikrocelularnog karcinoma pluća. (Thesis). Univerzitet u Beogradu. Retrieved from https://fedorabg.bg.ac.rs/fedora/get/o:10496/bdef:Content/get

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Marić, Dragana M., 1972-. “Procena kvaliteta života bolesnika sa završnim stadijumima hronične opstruktivne bolesti pluća i nemikrocelularnog karcinoma pluća.” 2016. Thesis, Univerzitet u Beogradu. Accessed June 01, 2020. https://fedorabg.bg.ac.rs/fedora/get/o:10496/bdef:Content/get.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Marić, Dragana M., 1972-. “Procena kvaliteta života bolesnika sa završnim stadijumima hronične opstruktivne bolesti pluća i nemikrocelularnog karcinoma pluća.” 2016. Web. 01 Jun 2020.

Vancouver:

Marić, Dragana M. 1. Procena kvaliteta života bolesnika sa završnim stadijumima hronične opstruktivne bolesti pluća i nemikrocelularnog karcinoma pluća. [Internet] [Thesis]. Univerzitet u Beogradu; 2016. [cited 2020 Jun 01]. Available from: https://fedorabg.bg.ac.rs/fedora/get/o:10496/bdef:Content/get.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Marić, Dragana M. 1. Procena kvaliteta života bolesnika sa završnim stadijumima hronične opstruktivne bolesti pluća i nemikrocelularnog karcinoma pluća. [Thesis]. Univerzitet u Beogradu; 2016. Available from: https://fedorabg.bg.ac.rs/fedora/get/o:10496/bdef:Content/get

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


NSYSU

29. Liu, Chien-Ting. Molecular Dynamic Simulation to Survey Possible Resistance Mechanisms of ALK Inhibitors to G1202R Mutation in EML4-ALK Translocation Positive Non-small Cell Lung Cancer.

Degree: Master, Institute of Medical Science and Technology, 2018, NSYSU

Non-small cell lung cancers (NSCLC) with ALK rearrangements are highly sensitive to ALK tyrosine kinase inhibition (TKI). The multi-targeted TKI crizotinib, ceritinib, alectinib, and brigatinib… (more)

Subjects/Keywords: molecular dynamic simulation; drug-resistant; tyrosine kinase inhibitor; ALK translocation; Non-small cell lung cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Liu, C. (2018). Molecular Dynamic Simulation to Survey Possible Resistance Mechanisms of ALK Inhibitors to G1202R Mutation in EML4-ALK Translocation Positive Non-small Cell Lung Cancer. (Thesis). NSYSU. Retrieved from http://etd.lib.nsysu.edu.tw/ETD-db/ETD-search/view_etd?URN=etd-0626118-123732

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Liu, Chien-Ting. “Molecular Dynamic Simulation to Survey Possible Resistance Mechanisms of ALK Inhibitors to G1202R Mutation in EML4-ALK Translocation Positive Non-small Cell Lung Cancer.” 2018. Thesis, NSYSU. Accessed June 01, 2020. http://etd.lib.nsysu.edu.tw/ETD-db/ETD-search/view_etd?URN=etd-0626118-123732.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Liu, Chien-Ting. “Molecular Dynamic Simulation to Survey Possible Resistance Mechanisms of ALK Inhibitors to G1202R Mutation in EML4-ALK Translocation Positive Non-small Cell Lung Cancer.” 2018. Web. 01 Jun 2020.

Vancouver:

Liu C. Molecular Dynamic Simulation to Survey Possible Resistance Mechanisms of ALK Inhibitors to G1202R Mutation in EML4-ALK Translocation Positive Non-small Cell Lung Cancer. [Internet] [Thesis]. NSYSU; 2018. [cited 2020 Jun 01]. Available from: http://etd.lib.nsysu.edu.tw/ETD-db/ETD-search/view_etd?URN=etd-0626118-123732.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Liu C. Molecular Dynamic Simulation to Survey Possible Resistance Mechanisms of ALK Inhibitors to G1202R Mutation in EML4-ALK Translocation Positive Non-small Cell Lung Cancer. [Thesis]. NSYSU; 2018. Available from: http://etd.lib.nsysu.edu.tw/ETD-db/ETD-search/view_etd?URN=etd-0626118-123732

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

30. Koinis, Filippos. Επίδραση της χημειοθεραπείας με ή χωρίς τον αντι-αγγειογενετικό παράγοντα Bevacizumab στα ανοσοκατασταλτικά κύτταρα σε ασθενείς με μη-μικροκυτταρικό καρκίνο του πνεύμονα.

Degree: 2018, University of Crete (UOC); Πανεπιστήμιο Κρήτης

 Introduction: Lung cancer (LC) is among the most frequent type of malignancies, accounting for 13% of the newly diagnosed cases worldwide in 2012. Non-small-cell lung(more)

Subjects/Keywords: Επίδραση; Χημειοθεραπεία; Ανοσοκαταστολή; Μη-Μικροκυταρικός Καρκίνος Πνεύμονα; Effect; Chemotherapy; Immunosuppression; Non-small cell lung cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Koinis, F. (2018). Επίδραση της χημειοθεραπείας με ή χωρίς τον αντι-αγγειογενετικό παράγοντα Bevacizumab στα ανοσοκατασταλτικά κύτταρα σε ασθενείς με μη-μικροκυτταρικό καρκίνο του πνεύμονα. (Thesis). University of Crete (UOC); Πανεπιστήμιο Κρήτης. Retrieved from http://hdl.handle.net/10442/hedi/43682

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Koinis, Filippos. “Επίδραση της χημειοθεραπείας με ή χωρίς τον αντι-αγγειογενετικό παράγοντα Bevacizumab στα ανοσοκατασταλτικά κύτταρα σε ασθενείς με μη-μικροκυτταρικό καρκίνο του πνεύμονα.” 2018. Thesis, University of Crete (UOC); Πανεπιστήμιο Κρήτης. Accessed June 01, 2020. http://hdl.handle.net/10442/hedi/43682.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Koinis, Filippos. “Επίδραση της χημειοθεραπείας με ή χωρίς τον αντι-αγγειογενετικό παράγοντα Bevacizumab στα ανοσοκατασταλτικά κύτταρα σε ασθενείς με μη-μικροκυτταρικό καρκίνο του πνεύμονα.” 2018. Web. 01 Jun 2020.

Vancouver:

Koinis F. Επίδραση της χημειοθεραπείας με ή χωρίς τον αντι-αγγειογενετικό παράγοντα Bevacizumab στα ανοσοκατασταλτικά κύτταρα σε ασθενείς με μη-μικροκυτταρικό καρκίνο του πνεύμονα. [Internet] [Thesis]. University of Crete (UOC); Πανεπιστήμιο Κρήτης; 2018. [cited 2020 Jun 01]. Available from: http://hdl.handle.net/10442/hedi/43682.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Koinis F. Επίδραση της χημειοθεραπείας με ή χωρίς τον αντι-αγγειογενετικό παράγοντα Bevacizumab στα ανοσοκατασταλτικά κύτταρα σε ασθενείς με μη-μικροκυτταρικό καρκίνο του πνεύμονα. [Thesis]. University of Crete (UOC); Πανεπιστήμιο Κρήτης; 2018. Available from: http://hdl.handle.net/10442/hedi/43682

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

[1] [2] [3] [4] [5] … [2935]

.